YOU HAVE QUESTIONS.
WE HAVE ANSWERS.

The following FAQs1-7 can help answer any questions you may still have about Bravecto.® If there is something more you want to know, you can always contact us for more information – or ask your veterinarian.

How is Bravecto different from other chewable or topical flea and tick treatments?

Bravecto is the only flea and tick treatment to last 12 weeks* with one convenient chew or topical dose.1,2 That means nearly 3X longer lasting protection than common monthly treatments. The long-lasting efficacy breaks the flea life cycle and drives fleas into extinction with one dose.3 And, Bravecto kills ticks faster, killing 100% of attached ticks in 12 hours – whereas other treatments can take over 48 hours.4

SAVE MORE WITH BRAVECTO

A single Bravecto treatment lasts for 12 weeks* compared to other products which must be given every month. That makes Bravecto a cost-effective option for keeping your pet protected. But now, you can save even more.

SEE OFFER

Try Bravecto and experience the difference it makes in the lives of you and your pet. Bravecto provides 12 weeks* of protection against fleas and ticks with a single treatment.1,2 That's easy and convenient treating, fewer chances to forget and a better experience for you and your pet, all taken care of with just one dose.

FIND A VET NEAR YOU

Bravecto is only available through your veterinarian. Find a veterinarian near you today to protect your pet with Bravecto.

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

Bravecto kills fleas and prevents flea infestations for 12 weeks. Bravecto Chew kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION:
Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto Topical for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.

References: 1. Bravecto Chews for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3. Dryden et al. Parasites & Vectors (2013) 6:126. 4. Burgio et al. Parasites & Vectors (2016) 9:626. 5. Companion Animal Parasite Council. CAPC Recommendations: Ticks. www.capcvet.org/capcrecommendations/ticks. Accessed January 21, 2015. 6. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 7. Walther FM et al. Parasites & Vectors (2014); 7:86. 8. Walther et al. Parasites & Vectors (2014) 7:481

Try Bravecto